Low Signal

SGI-110 Dose Escalation

SGI-110 Dose Escalation is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Previously Treated Metastatic Colorectal Cancer

Mechanism: Unknown

Modality: Unknown

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Scores

Risk-signal summary

Registry: 0/5

Timeline: 1/5

Recruitment burden: 1/5

Results availability: 0/5

Program risk: 1/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT01896856

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT01896856Low Signal (COMPLETED)stale_update_signalLow Signalstrict_eligibility_signal